hoodb.com

長聖(6712)新藥CAR001向衛生福利部食品藥物管理署(TFDA)提出治療晚期復發/難治性實體腫瘤(Relapsed/Refractory Solid Tumors)Phase Ⅰ/Ⅱa臨床試驗(12/1日股價198.5元)

|

You are leaving and open the following URL" of about "a 臨床試驗申請(12" news

news.google.com/rss/articles/CBMickFVX3lxTE5ycm40cktoVzVKT2JHaWlJVm5mOWdITUt2b1FFTTllTmlBenVMYUdUbC0tMklreE9lTzdQOUcxdjgyWV9TcFNVT003Zi1LTk5yaEpUdXJlZkJIZ19BYWRYclRQbzVwZWhFUC1nalBxVXdvQQ?oc=5


Continue Opne >

a 臨床試驗申請(12: 長聖(6712)新藥CAR001向衛生福利部食品藥物管理署(TFDA)提出治療晚期復發/難治性實體腫瘤(Relapsed/Refractory Solid Tumors)Phase Ⅰ/Ⅱa臨床試驗(12/1日股價198.5元)


More a 臨床試驗申請(12 news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/IE/a 臨床試驗申請(12.xml in /var/www/hoodb/function.php on line 339
1736679646-
Warning: file_put_contents(aCache/aaa/gnews/IE//a 臨床試驗申請(12.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About a 臨床試驗申請(12

from
1736679647-1736280941

Warning: filemtime(): stat failed for aCache/search/ie/a 臨床試驗申請(12 in /var/www/hoodb/function.php on line 339
1736679647-

a 臨床試驗申請(12, 長聖(6712)新藥CAR001向衛生福利部食品藥物管理署(TFDA)提出治療晚期復發/難治性實體腫瘤(Relapsed/Refractory Solid Tumors)Phase Ⅰ/Ⅱa臨床試驗(12/1日股價198.5元) 2022 a 臨床試驗申請(12

長聖(6712)新藥CAR001向衛生福利部食品藥物管理署(TFDA)提出治療晚期復發/難治性實體腫瘤(Relapsed/Refractory Solid Tumors)Phase Ⅰ/Ⅱa臨床試驗(12/1日股價198.5元)

Choose Your Country or Region


Back to Top



長聖(6712)新藥CAR001向衛生福利部食品藥物管理署(TFDA)提出治療晚期復發/難治性實體腫瘤(Relapsed/Refractory Solid Tumors)Phase Ⅰ/Ⅱa臨床試驗(12/1日股價198.5元)

Copyright © 2020-2021 hoodb.com. All Rights Reserved.